Higher body weight patients on clopidogrel maintenance therapy have lower active metabolite concentrations, lower levels of platelet inhibition, and higher rates of poor responders than low body weight patients.
about
Weight-based dosing in medication use: what should we know?Clinical pharmacokinetics and pharmacodynamics of clopidogrel.Development of a physiology-directed population pharmacokinetic and pharmacodynamic model for characterizing the impact of genetic and demographic factors on clopidogrel response in healthy adults.Evaluation of Acute In-stent Thrombosis during Stent-assisted Coil Embolization of Unruptured Intracranial Aneurysms
P2860
Higher body weight patients on clopidogrel maintenance therapy have lower active metabolite concentrations, lower levels of platelet inhibition, and higher rates of poor responders than low body weight patients.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Higher body weight patients on ...... than low body weight patients.
@en
Higher body weight patients on ...... than low body weight patients.
@nl
type
label
Higher body weight patients on ...... than low body weight patients.
@en
Higher body weight patients on ...... than low body weight patients.
@nl
prefLabel
Higher body weight patients on ...... than low body weight patients.
@en
Higher body weight patients on ...... than low body weight patients.
@nl
P2093
P2860
P1476
Higher body weight patients on ...... than low body weight patients.
@en
P2093
Brian A Moser
Chunmei Zhou
David Erlinge
David S Small
Dominick J Angiolillo
Henrik Wagner
Joseph A Jakubowski
Jurrien M Ten Berg
Kenneth J Winters
Patricia Brown
P2860
P2888
P304
P356
10.1007/S11239-013-0987-8
P577
2014-01-01T00:00:00Z